-
HPA042969-100UL
ANTI-C16ORF62 (C005B-212910)
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 16 open reading frame 62 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA041131-100UL
ANTI-C16ORF70 (C005B-212019)
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 16 open reading frame 70 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA041214-100UL
ANTI-C16ORF70 (C005B-212064)
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 16 open reading frame 70 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA041568-100UL
ANTI-C16ORF72 (C005B-212242)
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 16 open reading frame 72 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA049367-100UL
ANTI-C16ORF74 ANTIBODY PRODUCED IN RABBIT
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 16 open reading frame 74 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA041179-100UL
ANTI-C16ORF87 (C005B-212051)
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 16 open reading frame 87 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA040850-100UL
ANTI-C16ORF95 (C005B-211875)
Price: $1,013.20List Price: $1,125.78Immunogen cDNA: FLJ22477 fis, clone HRC10815 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are -
HPA042009-100UL
ANTI-C16ORF96 (C005B-212479)
Price: $1,013.20List Price: $1,125.78Immunogen Uncharacterized protein recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported -
HPA042058-100UL
ANTI-C16ORF96 (C005B-212512)
Price: $1,013.20List Price: $1,125.78Immunogen Uncharacterized protein recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported -
HPA046824-100UL
ANTI-C17ORF100 ANTIBODY PRODUCED IN RABBIT
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 17 open reading frame 100 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, -
HPA027266-100UL
ANTI-C17ORF104 ANTIBODY PRODUCED IN RABBIT PRESTIGE ANTIBODIES(R) POWERED BY ATLAS ANTIBODIES AFFINITY ISOLATED ANTIBODY BUFFERED
Price: $959.88List Price: $1,066.53The gene C17orf104, also referred to as MEIOC (meiosis specific with coiled-coil domain), is a meiosis prophase I-specific gene that encodes a protein with highly conserved coiled-coil domain at the C-terminal region. It is found to be expressed in -
HPA044348-100UL
ANTI-C17ORF39 ANTIBODY PRODUCED IN RABBIT
Price: $1,013.20List Price: $1,125.78Immunogen chromosome 17 open reading frame 39 recombinant protein epitope signature tag (PrEST) Application All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result,